ElderTech go-to-market is uniquely complex – three distinct buyer segments, a category most buyers still can't name, and institutional procurement cycles that outlast a normal sales quarter. We build GTM strategies that sequence these challenges in the right order so you build momentum instead of spinning wheels.
The Problem
Three buyer segments, zero repeatable sales process
Your product could be sold to older adults directly, to family caregivers, or to institutions like health systems and senior living operators. Each segment has different discovery channels, decision criteria, price sensitivity, and sales cycles. Most eldertech companies chase all three at once and never build a repeatable process in any of them. The result is a pipeline that looks busy but converts inconsistently quarter to quarter.
The category doesn't exist in your buyers' minds yet
When your buyer doesn't recognize your product category, every sales conversation starts with education, not evaluation. That extends sales cycles and blunts the demand-gen tactics that work in mature categories. You're not competing against other eldertech vendors for market share – you're competing against inertia, family skepticism, and the status quo of doing nothing. Your GTM has to budget time and content for that education burden explicitly.
Consumer acquisition economics don't work without institutional validation
Direct-to-consumer eldertech has brutal unit economics. Older adults are expensive to reach through digital channels, conversion rates stay low because trust barriers are high, and price sensitivity caps what you can charge. Most eldertech companies eventually discover that the path to consumer scale runs through institutional partners – health systems, insurers, and senior living operators who can deploy the product across a population they already serve.
Your sales team can't navigate healthcare procurement
If institutional sales is part of your GTM, you need people and process built for healthcare buying cycles – clinical evaluation committees, IT security reviews, compliance assessments, legal negotiations, and multi-month timelines. Reps who've only sold to SMBs or consumers are not equipped for this. The GTM plan has to account for the headcount, patience, and documentation these cycles actually require, not the timeline you'd want.
How We Help
We start with the hardest GTM decision in eldertech: which buyer segment to lead with. This isn't about picking one forever – it's about picking one first so you build traction, case studies, and revenue before expanding. We analyze your current pipeline, product capabilities, competitive position, and unit economics as part of a broader growth strategy engagement, and we make this call with data, not gut feel.
Once the lead segment is set, we build the GTM motion for that segment specifically. For consumer or caregiver-led strategies, that means defining acquisition channels, building the conversion funnel, establishing trust signals, and designing onboarding. For institutional-led strategies, that means identifying target accounts, building the enterprise sales toolkit, designing the pilot program framework, and assembling the outcomes evidence buyers ask for.
Positioning and messaging are calibrated to the lead segment as part of our brand positioning work. If you're going institutional first, messaging leads with outcomes data, compliance, and operational efficiency. If you're going consumer first, it leads with independence, ease of use, and peace of mind for the family. The framework is built to flex to other segments later without a rebrand.
We build the sales process and enablement materials your team actually executes with. For institutional sales, that includes pitch decks tailored to different stakeholders – clinical champions, IT, finance, operations – plus ROI calculators, compliance checklists, and reference management. For consumer sales, it includes site optimization, ad creative, email sequences, and partner channel development.
Winston Francois brings GTM operating experience across health and consumer technology. We've navigated this same multi-segment complexity before, and we know how to sequence the GTM so momentum builds in one segment instead of resources spreading thin across three.
What we deliver
- Segment prioritization analysis – data-driven decision on which buyer segment to lead with
- GTM strategy for lead segment – complete playbook with channels, messaging, and sales process
- Positioning framework – flexible enough to serve all segments while leading with one
- Sales enablement toolkit – segment-specific pitch materials, ROI tools, and compliance checklists
- 90-day launch plan with specific targets, milestones, and resource requirements
The biggest GTM mistake in eldertech is treating consumer and institutional sales as either/or. The companies that break out use institutional partnerships as the distribution channel for consumer adoption – health systems deploy the product to their patient populations, which solves the acquisition-cost problem and the trust problem at the same time.
Our Methodology
Our 90-day GTM sprint for eldertech starts with 30 days of analysis. We assess each buyer segment's attractiveness – market size, acquisition cost, sales cycle length, competitive intensity, and your current traction. We interview existing customers, analyze pipeline data, and evaluate product readiness for each segment. The output is a segment prioritization recommendation backed by data, not opinion.
Days 30-60 build the GTM infrastructure for the lead segment: positioning and messaging, sales process design, enablement materials, and the channels or partners needed for execution. For institutional-led strategies, this includes designing the pilot program structure and building the enterprise sales toolkit.
Days 60-90 are launch and validation. We activate the plan, support your sales team through initial opportunities, and measure early results against targets. Weekly reviews track progress and flag needed adjustments. The goal is a functioning GTM motion generating qualified pipeline by day 90, not a strategy deck that sits in a drive folder.
How We Work
The first 30 days require deep access to your business – CRM data, pipeline history, customer interviews, financial data, and product roadmap. We run 8-12 stakeholder and customer interviews alongside quantitative analysis, and present the segment prioritization recommendation to your leadership team by day 30.
Days 30-60 are a collaborative build phase. We work alongside your team to create the GTM toolkit, design processes, and prepare for launch, through 2-3 working sessions with leadership and weekly production sprints.
Days 60-90 are launch support. We coach your sales team on the new process, sit in on initial customer conversations, and stand up the measurement framework so GTM performance is visible at the executive level every month.
GTM engagements typically run 4-6 months: the initial sprint establishes the foundation, and subsequent months optimize based on real market data. The engagements that work best have direct CEO involvement throughout, because GTM strategy in eldertech requires alignment across product, clinical, sales, and marketing that no single department can force on its own.
- Clear segment prioritization with supporting data
- Repeatable sales process for lead buyer segment
- Institutional sales readiness (if applicable)
- Pipeline generation from focused GTM execution
If your eldertech / agetech company needs go-to-market leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a go-to-market strategy cost for an eldertech company?
The initial 90-day GTM sprint typically runs $25K-$50K, covering segment analysis, strategy development, sales enablement, and launch support. Ongoing execution support runs $15K-$25K per month after that. The investment is smaller than the alternative most eldertech companies default to: spending 12-18 months and several hundred thousand dollars trying to serve every segment before finding real traction in any one of them.
Should our eldertech company start with consumer, caregiver, or institutional sales?
It depends on your product, current traction, and unit economics. Consumer-led works when your product has strong word-of-mouth potential and manageable acquisition costs. Institutional-led works when you have real outcome data and a sales team that can navigate procurement. Caregiver-led works when caregivers are the ones deciding and paying. We analyze your specific situation before recommending one.
How long does it take to build a repeatable GTM motion in eldertech?
Expect 4-6 months to stand up a functioning GTM motion in your lead segment, and 12-18 months before it's truly repeatable with predictable unit economics. That's longer than a typical SaaS timeline because eldertech requires more buyer education and institutional sales cycles run long by design. Our 90-day sprint gets the foundation in place and validates the approach before you scale spend against it.
How do you handle the multi-stakeholder complexity in eldertech sales?
We map the buying committee for each segment and build messaging and materials for each stakeholder. In institutional sales, that can mean separate pitch tracks for clinical champions, IT security, finance, and operations. In consumer sales, it means messaging for both the end user and the family caregiver who often influences or funds the purchase. The GTM plan accounts for every stakeholder in the room, not just the person who signs.
What makes Winston Francois different for eldertech GTM?
We've built GTM strategies for companies facing this same multi-segment complexity – health tech sold to consumers, caregivers, and institutions at once. We know how to sequence segments, build cross-segment positioning, and avoid the trap of chasing everyone simultaneously. We bring operator experience from running GTM ourselves, not a generic consulting framework applied to a new logo.
What size eldertech company is the right fit for GTM strategy work?
Companies with a working product and some early customers, typically $500K-$20M in revenue. If you're pre-product, you need product development support first, not GTM strategy. If you're past $30M, you likely have enough internal data to build GTM in-house with targeted specialist support. The sweet spot is post-product, pre-scale companies still searching for the repeatable growth path.
